Stem Cell Therapy Market

Global Stem Cell Therapy Market Size, Forecasts, And Opportunities – Includes Stem Cell Therapy Market Share

Learn about the global stem cell therapy market through The Business Research Company, which provides information on stem cell therapy market size, stem cell therapy market drivers and restraints, stem cell therapy market players, the COVID-19 impact on the stem cell therapy market, and more.


The stem cell therapy market size is expected to grow from $4.01 billion in 2021 to $10.60 billion in 2026 at a rate of 21.4%. The stem cell therapy market size is then expected to grow at a CAGR of 11.4% from 2026 and reach $18.17 billion in 2031.


The rapid increase in the aging population is expected to increase the prevalence of cancer cases and chronic diseases, contributing to the growth of the stem cell therapy market.


Request A Sample For The Stem Cell Therapy Market Report:


Stem Cell Therapy Market
Stem Cell Therapy Market


The stem cell therapy market consists of the sales of stem cell therapy and related services by entities (organizations, sole traders, and partnerships) that provide stem cell therapy. Stem cell therapy promotes the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. Only goods and services traded between entities or sold to end consumers are included.


Global Stem Cell Therapy Market Segments Include:

By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

By Application: Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Others

By End-User: Hospitals, Research Centres, Clinics

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the global stem cell therapy market, accounting for 53.9% of the total in 2021.


Drug manufacturers are investing in developing induced pluripotent stem cell -derived NK cells, and a few have reached clinical trial phases. Companies in the market are combining iPSCs unique dual properties of unlimited self-renewal and differentiation potential to derive natural killer (NK) cell product to create more persistent and effective ‘killer’ cells.


TBRC’s Stem Cell Therapy Market Report Covers:

Major Market Players: Smith & Nephew plc, Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)


The Stem Cell Therapy Market Report 2022 is one of a series of new reports from The Business Research Company that provides stem cell therapy market overviews, analyzes and forecasts market size, share, stem cell therapy market players, stem cell therapy market segments and geographies, leading competitor revenues, profiles and market shares.


TBRC’s stem cell therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.


Here Is A List Of Similar Reports From The Business Research Company:

Cell Therapy Global Market Report 2022

Gene Therapy Global Market Report 2022

Microbiome Global Market Report 2022


Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.


Read more about us at


Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293


Follow us on LinkedIn:

Follow us on Twitter:

Check out our Global Market Model:


Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *